Transdermal Patches Containing Opioids in the Treatment of Patients with Chronic Pain

被引:1
|
作者
De Marco, Iolanda [1 ,2 ]
机构
[1] Univ Salerno, Dept Ind Engn, Via Giovanni Paolo II 132, I-84084 Fisciano, SA, Italy
[2] Univ Salerno, Res Ctr Biomat BIONAM, Via Giovanni Paolo II 132, I-84084 Fisciano, SA, Italy
关键词
fentanyl; buprenorphine; transdermal patches; reservoir and matrix systems; 20; MU-G/H; RELEASE TRAMADOL TABLETS; CHRONIC NONCANCER PAIN; BUPRENORPHINE PATCHES; POSTOPERATIVE PAIN; FENTANYL PATCHES; DELIVERY-SYSTEM; CANCER PAIN; OPEN-LABEL; MATRIX;
D O I
10.3390/pr11092673
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Transdermal delivery is a non-invasive route, used as an alternative to the oral route, to administer drugs through the skin surface. One of the fields in which they are particularly used is that of pain therapy. In this treatment, transdermal patches, particularly those containing opioids, are used to complement or replace orally administered drugs. First-generation patches are constituted by reservoir systems, where the drug is dissolved in a solvent and gelled with a polymer. In contrast, the active principle is incorporated into the polymer adhesive in more recent matrix patches. In this review, the main papers related to the production and employment of transdermal patches containing the two most used opioids, i.e., fentanyl and buprenorphine, have been critically analyzed. From the analysis of the literature, it is possible to deduce that the type of drug and the amount of drug present in the patch must be chosen not according to the origin of the pain but to the age of the patient, the area where the patch is applied, and the frequency at which the patch is replaced.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] OPIOIDS IN THE TREATMENT OF CHRONIC PAIN OF NONMALIGNANT ORIGIN
    MERRY, AF
    SCHUG, SA
    RICHARDS, EG
    LARGE, RG
    NEW ZEALAND MEDICAL JOURNAL, 1991, 104 (925) : 520 - 521
  • [22] Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment
    Jui-Hung Tsai
    I-Ting Liu
    Pei-Fang Su
    Ying-Tzu Huang
    Ge-Lin Chiu
    Yu-Yeh Chen
    Wei-Shu Lai
    Peng-Chan Lin
    BMC Palliative Care, 22
  • [23] Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment
    Tsai, Jui-Hung
    Liu, I-Ting
    Su, Pei-Fang
    Huang, Ying-Tzu
    Chiu, Ge-Lin
    Chen, Yu-Yeh
    Lai, Wei-Shu
    Lin, Peng-Chan
    BMC PALLIATIVE CARE, 2023, 22 (01)
  • [24] Noninterventional Study of Transdermal Fentanyl (Fentavera) Matrix Patches in Chronic Pain Patients: Analgesic and Quality of Life Effects
    Heim, Manuel
    PAIN RESEARCH AND TREATMENT, 2015, 2015
  • [26] Treatment for patients with sleep apnea on opioids for chronic pain: results of the OpSafe trial
    Wasef, Sara
    Mir, Soodaba
    Ryan, Clodagh
    Waseem, Rida
    Bellingham, Geoff
    Kashgari, Alia
    Wong, Jean
    Chung, Frances
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2021, 17 (04): : 819 - 824
  • [27] Practice guidelines for transdermal opioids in malignant pain
    Skaer, TL
    DRUGS, 2004, 64 (23) : 2629 - 2638
  • [28] Practice Guidelines for Transdermal Opioids in Malignant Pain
    Tracy L. Skaer
    Drugs, 2004, 64 : 2629 - 2638
  • [29] Transdermal and oral opioids for outpatient pain therapy
    Hoeer, A.
    Kurepkat, M.
    Gottberg, A.
    Haeussler, B.
    SCHMERZ, 2008, 22 (02): : 156 - 163
  • [30] OTC Transdermal Analgesic Patches in Pain Management
    Lisi, Donna M.
    US PHARMACIST, 2019, 44 (03) : 15 - 21